DREADDAAV

Takahito Miyake1, Kaho Tanaka1, Yutsuki Inoue1

  • 1Department of Systems Biology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyō-ku, Kyoto 606-8501, Japan.

Cell reports methods
|October 22, 2024
PubMed
概括

研究人员开发了更小的设计者受体,仅由设计者药物 (DREADDs) 激活,miniDq和miniDi. 这些紧的DREADD能够在单个病毒载体内实现双重刺激和抑制的神经元控制,用于先进的神经科学研究.